Volume Spike Investor

ACS (ACS) is being bought by Xerox (XRX) for $6.4 billion in cash and stock, an extraordinary deal for ACS shareholders ACS stock is up 21% to $57.25, almost $5 above its 52-week high. Xerox shares are down almost 10% to $8.17 on the other hand Douglas A. McIntyre

Cal-Maine (CALM) is down almost 14% to $24 on poor earnings. For the first quarter of fiscal 2010, net sales were $187.7 million, compared with net sales of $206.9 million for the first quarter of fiscal 2009. The Company reported net loss of $3.8 million, or $0.16 per basic and diluted share, for the first quarter of [...]

Gander Mountain (GMTN) will go private and its shares are up 31% at $5.02. The price could go higher if shareholder object. The firm’s 52-week high is $6.49. A special committee of the company’s board of directors, comprised of independent directors, has recommended, and the board of directors has approved, plans to cease the registration [...]

Covidien (COV) has reached a definitive agreement to acquire Aspect, a global market leader in brain monitoring technology. The Boards of Directors of both companies have unanimously approved the transaction, pursuant to which a wholly owned subsidiary of Covidien will pay $12.00 in cash per Aspect share for a total of approximately $210 million, net of [...]

Tibco (TIBX) is up 7% in light volume after posting strong earnings. Total revenue for the third quarter of fiscal 2009 was $150.3 million and GAAP net income was $14.9 million, or $0.09 per diluted share. This compares to total revenue of $162.3 million and GAAP net income of $11.1 million, or $0.06 per diluted [...]

United Community Banks (UCBI) is down almost 9% on over 135,00o shares The bank said that it has priced a public offering of 38,700,000 shares of common stock at $5.00 per share for gross proceeds of $193.5 million. United expects to close the sale of the shares of common stock on or about September 30, [...]

Biopharma Allos Therapeutics (ALTH) is up 15% on over 500,000 shares. The firm said the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). FOLOTYN is the first and only drug approved [...]

RIM (RIMM) is down over 11% on almost 700,000 shares after announcing poor earnings after the market yesterday Douglas A. McIntyre

Conexant (CNXT) it intends to offer to sell, subject to market and other conditions, 7 million shares of its common stock in an underwritten public offering. The stock down 8%. Douglas A. McIntyre

Hercules OffShore (HERO) is trading off by 11% to $5.58 against a 52-week high of $18.09. Hercules Offshore forecast third-quarter revenue of $155 million to $160 million, below what analysts have been expecting. The company was forecsast to do over $165. Hercules also said it would offer up to 17.5 million shares of stock. Douglas [...]